LENZ · XBRL financial data

LENZ Therapeutics financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (LENZ's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Revenue from contracts with customers————year only05,00012,5001,588*1,9015,4863,384
Cost of goods and services sold————year only000418*1,076280454
Research and development1*10,5376,9456,4515,868*5,8189,0613,7910*000
Selling, general and administrative5,453*5,5517,4076,4949,357*11,11312,79627,59639,633*44,96039,37835,848
General and administrative14,601*———————————
Total operating expenses25,555*16,08814,35212,94515,225*16,93121,85731,387————
Operating income (loss)(25,555)*(16,088)(14,352)(12,945)(15,225)*(16,931)(16,857)(18,887)(38,463)*(44,135)(34,172)(32,918)
Interest income851*7882,4632,7362,566*2,3232,2462,2012,986*2,6442,2701,985
Other income (expense)2,562*(1,348)1,635(6)8*(11)199(14)(417)*3(13)(36)
Income tax expense (benefit)year only—001*—50002*—30
Net income (loss)(22,918)*(16,648)(10,254)(10,215)(12,652)*(14,619)(14,912)(16,700)(35,896)*(41,488)(31,918)(30,969)
Earnings per share, basic USD per share(0.39)*(3.53)(0.40)(0.38)—(0.53)(0.53)(0.59)(1.16)*(1.32)(1.02)(0.99)
Earnings per share, diluted USD per share(0.39)*(3.53)(0.40)(0.38)—(0.53)(0.53)(0.59)(1.16)*(1.32)(1.02)(0.99)
Weighted average shares, basic thousands of shares58,166*4,71825,60927,172—27,52628,07928,54131,071*31,35331,37431,420
Weighted average shares, diluted thousands of shares58,166*4,71825,60927,172—27,52628,07928,54131,071*31,35331,37431,420

Balance sheet

CSV

Fiscal quarters (LENZ's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Cash and cash equivalents184,259200,35784,03541,04620,15823,04237,60825,39925,17924,77224,20830,553
Marketable securities012,922112,077176,061————————
Marketable securities, non-current0———————————
Accounts receivable————0———329343442913
Inventory————0——9492,9363,4984,1214,760
Prepaid and other current assets2,1603,2813,1243,4832,7733,7693,9693,8765,8006,1418,7163,921
Total current assets188,021216,674199,350220,704211,917197,859213,602206,997301,412268,367233,282206,897
Property and equipment, net0491643726519261,1691,2581,1891,0961,002640
Right-of-use asset3215781,7271,5331,3381,069959847734619521421
Total assets188,456217,322202,639224,007215,304201,252217,332210,704305,876272,535236,596209,749
Accounts payable2507,1314,4062,7624,2573,6612,8544,3234,16710,9296,6485,517
Accrued liabilities12,80311,7574,1774,9486,1494,9087,54411,99317,02014,8779,77912,233
Total current liabilities4,79718,8888,5837,71010,4068,56910,39816,31621,18725,80617,21217,750
Lease liability, non-current771561,0529538146735694613502371220
Total liabilities4,87419,1559,7188,72711,2209,24210,96716,77721,53726,04317,33417,750
Accumulated deficit(367,054)(111,893)(122,147)(132,362)(145,014)(159,633)(174,545)(191,245)(227,141)(268,629)(300,547)(331,516)
Total stockholders' equity183,582198,167192,921215,280204,084192,010206,365193,927284,339246,492219,262191,999
Total liabilities and equity188,456217,322202,639224,007215,304201,252217,332210,704305,876272,535236,596209,749
Common shares outstanding (cover page) thousands of shares58,23725,53427,49727,50127,54328,14628,52231,29031,35431,35431,42031,421

Cash flows

CSV

Fiscal quarters (LENZ's year ends in late December)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 30, 2026
Net income (loss)(22,918)*(16,648)(10,254)(10,215)(12,652)*(14,619)(14,912)(16,700)(35,896)*(41,488)(31,918)(30,969)
Stock-based compensation2,305*9471,597*2,191*1,630*2,5552,845*3,469*3,678*4,3194,472*4,134*
Depreciation and amortization4*518*10*25*3619*125*107*111110*109*
Net cash from operating activitiesyear only(23,937)(15,795)*(10,581)*(9,078)*(16,049)(11,508)*(8,588)*(33,025)*(33,582)(38,713)*(22,311)*
Purchases of property and equipment50*0133*186*149*110240*439*38*1816*0*
Net cash from investing activities47,082*18,000(98,390)*(62,226)*(11,863)*18,889(414)*(4,333)*(89,810)*33,16137,754*28,656*
Proceeds from issuing common stock0*53,387(3,563)*29,774*(85)*0——————
Net cash from financing activities66*171,268(2,137)*29,818*53*4426,488*598*122,615*14395*0*
Net change in cash1,271*165,331(116,322)*(42,989)*(20,888)*2,88414,566*(12,323)*(220)*(407)(564)*6,345*

Compare with peers

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.